Alleviant Medical announced today that it received FDA investigational device exemption (IDE) and breakthrough device designation for its atrial shunt.
AccurKardia announced today that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia detection software.
Insulin delivery technology developer CeQur today announced a significant funding round to support its commercialization efforts.
Francis Medical announced today that it completed an oversubscribed $80 million Series C equity financing.
Fire1 announced today that it completed a $120 million financing round to accelerate the advancement of its heart failure management system.